Medifast Inc (MED)
NYSE:MED

Medifast (MED) Technical Analysis

1,171 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Medifast Inc’s (MED) Moving Averages Convergence Divergence (MACD) indicator is -0.55, suggesting Medifast Inc is a Sell.
Medifast Inc’s (MED) 20-Day exponential moving average is 19.53, while Medifast Inc’s (MED) share price is $20.49, making it a Buy.
Medifast Inc’s (MED) 50-Day exponential moving average is 22.04, while Medifast Inc’s (MED) share price is $20.49, making it a Sell.

Medifast (MED) Pivot Points

Jul 27, 2024, 06:57 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
17.74
18.28
18.91
19.45
20.07
20.61
21.24
Fibonacci
18.28
18.73
19.00
19.45
19.89
20.16
20.61
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Medifast (MED) Moving Averages

Jul 27, 2024, 06:57 PM
Period
Simple
Exponential
MA5
19.30Buy
19.54Buy
MA10
19.12Buy
19.32Buy
MA20
19.34Buy
19.53Buy
MA50
21.22Sell
22.04Sell
MA100
27.06Sell
28.77Sell
MA200
44.72Sell
44.72Sell
Medifast Inc’s (MED) 10-Day exponential moving average is 19.32, while Medifast Inc’s (MED) share price is $20.49, making it a Buy.
Medifast Inc’s (MED) 100-Day exponential moving average is 28.77, while Medifast Inc’s (MED) share price is $20.49, making it a Sell.
Medifast Inc’s (MED) stock price is $20.49 and Medifast Inc’s (MED) 50-day simple moving average is 21.22, creating a Sell signal.
Medifast Inc’s (MED) stock price is $20.49 and Medifast Inc’s (MED) 100-day simple moving average is 27.06, creating a Sell signal.
Medifast Inc’s (MED) stock price is $20.49 and Medifast Inc’s (MED) 200-day simple moving average is 44.72, creating a Sell signal.

Medifast (MED) Technical Indicators

Jul 27, 2024, 06:57 PM
Name
Value
Implied Action
RSI (14)
54.37
Neutral
STOCH (9,6)
73.60
Neutral
STOCHRSI (14)
73.60
Neutral
MACD (12,26)
-0.55
Sell
ADX (14)
15.62
Buy
Williams %R
-4.01
Sell
CCI (14)
81.35
Neutral
ATR (14)
0.97
-
Ultimate Oscillator
59.36
Neutral
ROC
10.70
Buy
Medifast Inc’s (MED) Relative Strength Index (RSI) is 54.37, creating a Neutral signal.
Medifast Inc’s (MED) Trend Strength Indicator (ADX) is 15.62, creating a Buy signal.
Medifast Inc’s (MED) Commodity Channel Index (CCI) is 81.35, creating a Neutral signal.
Medifast Inc’s (MED) Price Rate of Change (ROC) is 10.70, creating a Buy signal.

FAQ

Is MED a Buy, Hold, or Sell?
Based on MED’s technical indicators, MED is a Hold.
    What is MED’s RSI (14)?
    MED’s RSI (14) is 54.37, which suggests MED is a Neutral.
      What is MED’s MACD?
      MED’s MACD is -0.55, which suggests MED is a Sell.
        What is MED’s 5-day moving average?
        MED’s 5-day moving average is 19.30, which suggests MED is a Buy.
          What is MED’s 20-day moving average?
          MED 20-day moving average is 19.34, which suggests MED is a Buy.
            What is MED’s 50-day moving average?
            MED’s 50-day moving average is 21.22, which suggests MED is a Sell.
              What is MED’s 200-day moving average?
              MED’s 200-day moving average is 44.72, which suggests MED is a Sell.
                What is MED’s Williams % R (14)?
                MED’s Williams % R (14) is -4.01, which suggests MED is a Sell.
                  What is MED’s CCI (14)?
                  MED’s CCI (14) is 81.35, which suggests MED is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis